Quanli Gao

机构：Zhengzhou University, Henan Cancer Hospital, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-9947-8818

发表论文 145 篇 · 总被引 2806 次 · h-index 23

代表论文

• Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial (2024 · 癌症：英文版 · 被引 45)
• The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer (2023 · Cancer Biology and Medicine · 被引 23)
• The inter-link of ageing, cancer and immunity: findings from real-world retrospective study (2023 · Immunity & Ageing · 被引 16)
• Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 13)
• Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint (2023 · Frontiers in Immunology · 被引 9)
• Transient-resting culture after activation enhances the generation of CD8+ stem cell-like memory T cells from peripheral blood mononuclear cells (2024 · Translational Oncology · 被引 3)